UBC's Blog

UBC is committed to sharing ideas & insights with the pharmaceutical & biotech industry to address the full product lifecycle & support the development & commercialization of safe & effective products.

 

- April 01, 2019
United BioSource LLC (UBC) goes live with its new version of UBC Pathways™ Electronic Benefits Verification (eBV) reaching more than 65% of covered lives in America.   UBC's eBV solution is now benefitting more patients than...
Natalie O’Donnell, Executive Director, Safety, Epidemiology, Registries & Risk Management - March 22, 2019
How do you determine if a REMS is needed during product development? A REMS should be considered when risk mitigation efforts are required beyond product labeling and routine pharmacovigilance. The types of REMS as defined by the...
Gretchen Dieck, MPhil, PhD, Vice President, Safety, Epidemiology, Registries & Risk Management, Ben Newton, Software Engineer, Database Analytics Automation, and Jamie Reifsnyder, Business Analyst, Database Analytics Automation - March 18, 2019
UBC Has You Covered UBC is introducing PVPlan™ automated software for signal management and tracking for pharmacovigilance (PV). The easy-to-use, point-and-click interface lets you track and manage your PV team with ease, while...
Wenda Brennan, RPh, Vice President, Global Safety & Pharmacovigilance - March 14, 2019
Traditionally, sources of adverse event reporting included the clinical trial investigator sites, post marketing medical information call centers, and local QPs in Europe.  However, currently, potential adverse event reporting is...
Shazia Ahmad, Director, Patient & Physician Services - March 07, 2019
Rare Disease Day is the biggest day of the year for the rare disease community. Since 2009, the National Institutes of Health (NIH) Clinical Center and National Center for Advancing Translational Sciences (NCATS) have hosted Rare...

Pages